Mutations in ribosomal proteins and ribosomal RNA confer macrolide resistance in human Ureaplasma spp

Li Xiao1, Donna M Crabb, Lynn B Duffy

  • 1Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35249, USA.

Insights

Genetic mutations in 23S rRNA and ribosomal protein L4 likely cause macrolide resistance in Ureaplasma species. This resistance was uncommon, unlike widespread tetracycline resistance observed in the study.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Antimicrobial Resistance

Background:

  • Ureaplasma species are common human commensals, but can cause opportunistic infections.
  • Macrolide antibiotics are crucial for treating Ureaplasma infections.
  • Understanding macrolide resistance mechanisms is vital for effective treatment strategies.

Purpose of the Study:

  • Investigate the genetic basis of macrolide resistance in Ureaplasma isolates.
  • Determine the prevalence of macrolide resistance compared to tetracycline resistance.

Main Methods:

  • Analyzed six Ureaplasma isolates with high erythromycin minimum inhibitory concentrations (MICs).
  • Examined point mutations in domain V of 23S ribosomal RNA (rRNA).
  • Sequenced ribosomal protein L4 genes for mutations.

Main Results:

  • Point mutations in 23S rRNA domain V and/or ribosomal protein L4 genes were identified as probable causes of macrolide resistance.
  • Macrolide resistance was found to be uncommon in the studied isolates.
  • Tetracycline resistance was highly prevalent, affecting 33% of isolates.

Conclusions:

  • Genetic mutations in specific rRNA and ribosomal protein genes are key drivers of macrolide resistance in Ureaplasma.
  • The low prevalence of macrolide resistance contrasts sharply with the high rate of tetracycline resistance.
  • Findings highlight the need for ongoing surveillance of antimicrobial resistance patterns in Ureaplasma.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...